Bioceres Crop Solutions Corp Stock Price, News & Analysis

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced that Brazil's National Biosafety Commission has approved the commercialization and cultivation of HB4 Wheat. This follows an earlier approval for food and feed use in November 2021. The decision not only opens the Brazilian market but also allows for further collaboration with EMBRAPA to develop local wheat varieties. HB4 Wheat can increase yields by over 40% in water-stressed areas and is expected to add $15-$20 million in EBITDA by FY24. Brazil plants 2-3 million hectares of wheat annually, contributing significantly to South America's wheat acreage.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported a 7% decline in total revenues for Q2 FY23, totaling $94.4 million, primarily due to severe drought conditions in Argentina, which halved wheat output. However, sales in North America partially offset losses. The adjusted EBITDA stood at $10.3 million, a decrease of 43% YoY, with gross profit down 28%. Despite adverse weather, the HB4 Wheat technology showed a 43% yield improvement versus conventional varieties, and HB4 Soy sales were initiated in Brazil. Management expects a resumption of growth in the latter half of the fiscal year as conditions improve.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will host a conference call on February 9, 2023, at 8:30 a.m. ET, to discuss its second-quarter results ending December 31, 2022. The call, led by CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of Investor Relations Paula Savanti, will follow a press release with detailed financial data. Interested participants can access the call via toll-free and international dial-in numbers or through a live webcast, with a replay available until February 14, 2023.

Bioceres is focused on sustainable agriculture and offers innovative crop productivity solutions.

The merger between Calyxt and Cibus aims to create a leading entity in precision gene editing and sustainable agriculture. Under the all-stock deal, Calyxt shareholders will retain approximately 5% of the new company, which will operate under the name Cibus Inc. Key applications include enhancing productivity traits in seeds and developing renewable low-carbon ingredients. The merger supports a strong collaboration pipeline with major seed companies, with three productivity traits expected to launch in early 2023. Both companies anticipate significant regulatory developments that could enhance market opportunities.

On January 3, 2023, S&W Seed Company (SANW) and Trigall Genetics announced a joint venture, Trigall Australia, where Trigall Genetics will own 80%. This new entity aims to develop and market high-performing wheat varieties across Australia, utilizing S&W's commercial reach and Bioceres Crop Solutions' technologies. The program will include drought-resistant HB4 technology and EcoWheat technologies to enhance yields in drought-affected areas. The partnership marks a significant step in Trigall's international expansion strategy, leveraging a global genetic library and advanced breeding expertise.

Bioceres Crop Solutions Corp. (BIOX) reported a 71% increase in revenues for 1Q23, totaling $127.1 million, compared to pro forma figures from 1Q22. Gross profit rose 52% to $51.4 million, while Adjusted EBITDA nearly doubled, reaching $24.5 million. The growth was driven by strong sales of micro-beaded fertilizers and biological products. A significant agreement with Syngenta Seedcare aims to enhance global inoculant growth, with a minimum profit share of $23 million per year. Despite a severe drought in Argentina, management remains optimistic about future growth.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will host a conference call on November 10, 2022, at 8:30 a.m. ET to discuss its first quarter results for the period ending September 30, 2022. CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of Investor Relations Paula Savanti will lead the discussion, followed by a Q&A session. Investors can join via a toll-free number and access the call through a webcast. A replay will be available until November 15, 2022.

Syngenta Seedcare has partnered with Bioceres Crop Solutions (NASDAQ: BIOX) to exclusively commercialize its biological seed treatment solutions globally. This collaboration, stemming from a productive 20-year relationship, aims to accelerate the registration of existing products while jointly developing new solutions. The biological seed treatment market is expected to grow from $0.6 billion in 2020 to $1.6 billion by 2030. The agreement will enhance the availability of sustainable farming solutions while focusing on key markets like Brazil and China.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported strong financial results for the fourth quarter and fiscal year ended June 30, 2022. The fourth quarter saw a 44% increase in comparable revenues to $104.1 million, while full fiscal year revenues rose 62% to a record $319.3 million. HB4 Wheat revenues of $12.4 million marked a 94% increase YoY. Gross profit for the quarter was $41.4 million, a 32% increase, and Adjusted EBITDA reached $61.9 million, up 24%.

Successful mergers and ongoing regulatory approvals for HB4 products further bolster the company’s growth prospects.